07.15.26 -- FDA's Guidance On Cell And Gene CMC Codifies Flexibility

Environmental DNA enables researchers to detect species and pathogens through the genetic traces they leave behind. New molecular tools now make it possible to analyze these faint signals in real time.

With shifting needs and requirements in advanced therapy manufacturing, embedding infrastructure flexibility is vital. Discover how to balance these variables for long-term success.

Evaluate your quality processes and compliance needs with a modern QMS framework. Connect data, automate workflows, and reduce errors across your operations.

See how strategic EU dossier adaptation and Swiss-specific regulatory expertise enabled a successful SwissMedic submission and accelerated market access for an oncology therapy.

EU GMP Annex 1 now defines clear expectations for glove integrity testing. Examine how reliability, efficiency, and equipment usability are becoming essential factors for maintaining compliance.

Rising regulatory demands require strong CMC, validated analytics, and inspection-ready operations. Early alignment of quality, scalability, and risk management is key to cell therapy commercialization.

Translating EU GMP Annex 1 into consistent site-level practice is where most struggle. Hear why the global-to-local execution gap remains the industry's biggest compliance challenge and what it takes to close it.

Inspection‑readiness depends on consistency and control. Explore strategies for standardizing cell sorting workflows, minimizing variability, and using electronic records to support compliance.

Underestimating E&L risks can delay approvals. A risk‑based, product‑specific approach — supported by strong analytics and toxicology — helps teams identify issues early and move forward with confidence.

Gain a clear roadmap for investigators, sponsors, and IRBs. This shift toward transparency replaces regulatory guesswork with predictable standards for every partner in the research ecosystem.

Stop losing time and capacity to manual paperwork. Learn how digital workflows eliminate compliance risks and unlock the actionable data needed to optimize life sciences manufacturing.

Watch how applying Quality by Design principles to automated labeling platforms utilizes robotics to eliminate manual errors and seamlessly adapt to future pharmaceutical packaging formats.